C. Lange (Borstel, Germany), C. Fléchet (Berlin, Germany)
Early effectiveness and safety of a modified shorter all-oral regimen for MDR/RR-TB in China
W. Nie (Beijing, China), J. Du (Wuhan, China), Y. Liu (Qingdao, China), Q. Wu (Xi'an, China), F. Ren (Xi'an, China), Q. Cai (Hangzhou, China), Y. Zhang (Nanjing, China), N. Chu (Beijing, China)
|  |
Drug tolerance predicts clinical outcomes in mycobacterial lung infections
A. Jovanovic (Basel, Switzerland), F. Bright (Basel, Switzerland), B. Wicki (Basel, Switzerland), L. Sauteur (Basel, Switzerland), A. Wüst (Basel, Switzerland), D. Grogono (Cambridge, United Kingdom), M. Tamm (Basel, Switzerland), P. Dehio (Basel, Switzerland), J. Nemeth (Zürich, Switzerland), M. Abanto (Basel, Switzerland), R. Thomson (Brisbane, Australia), S. Bell (Brisbane, Australia), A. Floto (Cambridge, United Kingdom), L. Boeck (Basel, Switzerland)
| |
Multifocal tuberculosis in the immunocompetent patient
Z. Laklaai (casablanca, Morocco), K. Channoune (casablanca, Morocco), N. Zaghba (casablanca, Morocco), H. Benjelloune (casablanca, Morocco), N. Yassine (casablanca, Morocco)
|  |
Factors associated with sputum culture conversion in patients with multidrug-resistant tuberculosis
G. Musteikiene (Kaunas, Lithuania), S. Miliauskas (Kaunas, Lithuania)
| |
Isoniazid-induced hepatotoxicity in latent tuberculosis patients
B. S. Silva (Porto, Portugal), N. Faria (Porto, Portugal), I. Costa (Porto, Portugal), R. Reis (Porto, Portugal)
| |
Study of rifampicin and silver nanoparticle composite efficacy on rifampicin-resistant Mycobacterium tuberculosis strains
N. Kiria (Tbilisi, Georgia), T. Avaliani (Tbilisi, Georgia), N. Bablishvili (Tbilisi, Georgia), N. Kiria (Tbilisi, Georgia), G. Phichkhaia (Tbilisi, Georgia)
| |
Association between PD-L1 expression in monocytes and treatment outcomes in active pulmonary tuberculosis- human and animal model
J. Feng (Taipei, Taiwan), C. Shu (Taipei, Taiwan), S. Pan (Taipei, Taiwan), J. Hung (Taipei, Taiwan), P. Hsu (Taipei, Taiwan), W. Su (Taipei, Taiwan), Y. Chen (Taipei, Taiwan)
| |
Mathematical model for predicting the treatment effectiveness of MDR-TB based on Human-beta-defensin-1 level
O. Pogorelova (Kharkiv, Ukraine), O. Shevchenko (Kharkiv, Ukraine), I. Ovcharenko (Kharkiv, Ukraine), O. Hovardovska (Kharkiv, Ukraine), O. Shvets (Kharkiv, Ukraine)
| |
Side effects of anti-tuberculosis treatment: comparison between combined and dissociated treatment
S. Bouchareb (Mahdia, Tunisia), M. Ammar (Mahdia, Tunisia), A. Ben Salem (Mahdia, Tunisia), S. Boujnah (Mahdia, Tunisia), A. Zaara (Mahdia, Tunisia), T. Imen (Mahdia, Tunisia), L. Boussoffara (Mahdia, Tunisia), J. Knani (Mahdia, Tunisia), N. Boudawar (Mahdia, Tunisia)
| |
Usage of silver nanoparticles to restore Moxifloxacin efficacy for fluoroquinolone-resistant M.tuberculosis cultures.
T. Avaliani (Tbilisi, Georgia), N. Kiria (Tbilisi, Georgia), N. Bablishvili (Tbilisi, Georgia), N. Kiria (Tbilisi, Georgia), G. Phichkhaia (Tbilisi, Georgia)
| |
A retrospective study evaluating the effect of Prednisolone on the radiological sequelae of Tuberculous pleurisy
J. Zhang (London, United Kingdom), U. Ahmed (London, United Kingdom), L. Brown (London, United Kingdom), O. Kadwani (London, United Kingdom), R. Breen (London, United Kingdom), P. Sivakumar (London, United Kingdom)
| |
Place of surgery in the management of lymph node tuberculosis
a. abdelkbir (ariana, Tunisia), K. Ben Amara (Ariana, Tunisia), M. Abdennadher (Ariana, Tunisia), H. Zribi (Ariana, Tunisia), A. Marghli (Ariana, Tunisia)
| |
Comparison of resolution of Tuberculous pleural effusion on Anti – tubercular treatment with and without steroids : A one-year follow–up
R. BHINGARDEVE (Mumbai, India), S. Mante (Mumbai, India), N. Ajwani (Mumbai, India), S. Waghmare (Mumbai, India), S. Thorve (Mumbai, India), J. Nair (Mumbai, India)
| |
Improvement in the management of nontuberculous mycobacteria after lobar collapse therapy with Endobronchial valves ( EBV)
V. Luzzi (Firenze (FI), Italy), J. Mencarini (Firenze (FI), Italy), S. Tomassetti (Firenze (FI), Italy), L. Corbetta (Firenze (FI), Italy)
| |
Not always COVID - pulmonary BCGosis as an unexpected cause of severe respiratory failure and massive ground glass opacities in the lungs.
K. Lewandowska (Warszawa, Poland), A. Lewandowska (Warszawa, Poland), I. Baranska (Warszawa, Poland), M. Klatt (Warszawa, Poland), E. Augstynowicz-Kopec (Warszawa, Poland), W. Tomkowski (Warszawa, Poland), M. Szturmowicz (Warszawa, Poland)
| |
Prevalence of sub-optimal drug levels of Rifampicin, Isoniazid and Pyrazinamide among tuberculosis patients in Sydney, Australia. A pilot study.
A. Byrne (Sydney (NSW), Australia), R. Wong (Sydney (NSW), Australia), D. Marriott (Sydney (NSW), Australia), D. Kocic (Sydney (NSW), Australia), J. Alffenaar (Sydney (NSW), Australia), J. Cho (Sydney (NSW), Australia), B. Marais (Sydney (NSW), Australia)
| |
Chest wall tuberculosis: a surgical experience
W. SAIDANI (Ariana, Tunisia), I. Bouacida (Ariana, Tunisia), A. Abdelkebir (Ariana, Tunisia), H. Zribi (Ariana, Tunisia), M. Abdennadher (Ariana, Tunisia), C. Jaber (Ariana, Tunisia), I. Moussa (Ariana, Tunisia), S. Zairi (Ariana, Tunisia), A. Marghli (Ariana, Tunisia), a. abdelkbir (ben arous, Tunisia)
| |
Regional differences in prescribing pyrazinamide for tuberculosis treatment
H. Matsumoto (Kanagawa, Japan), N. Kobayashi (Kanagawa, Japan), N. Fukuda (Kanagawa, Japan), A. Kaneko (Kanagawa, Japan), A. Izawa (Kanagawa, Japan), K. Somekawa (Kanagawa, Japan), C. Kamimaki (Kanagawa, Japan), S. Kubo (Kanagawa, Japan), K. Tanaka (Kanagawa, Japan), K. Seki (Kanagawa, Japan), H. Fujii (Kanagawa, Japan), A. Aoki (Kanagawa, Japan), Y. Tagami (Kanagawa, Japan), K. Watanabe (Kanagawa, Japan), N. Horita (Kanagawa, Japan), Y. Hara (Kanagawa, Japan), T. Kaneko (Kanagawa, Japan)
| |
Priority identification in the clinical case management of multidrug resistant Tuberculosis (MDR-TB) in Bangladesh
F. Zaman (Dhaka, Bangladesh), M. Asaduzzaman (Oslo, Norway)
| |
The impact of diabetes mellitus on the anti-TB treatment outcome, a series of cases study
T. Osipov (Chisinau, Republic of Moldova), E. Lesnic (Chisinau, Republic of Moldova), A. Malic (Chisinau, Republic of Moldova)
| |